During a retroactive review of past complaints for potential adverse events, conducted as a capa in response to a recent fda inspection, a reportable adverse event was discovered.The wife of a (b)(6) male pt called zoll customer support to report that the pt passed away on (b)(6) 2012.The device was alarming and the pt was unconscious.Paramedics transported the patient to the hospital, where he later passed away.The lifevest detected an arrhythmia (vt degrading to vf) at 00:55:09 on (b)(6) 2012.The response buttons were pressed at 00:55:15, delaying treatment.A second treatable arrhythmia (vf) was detected at 1:00:30.The response buttons were used again to delay treatment at 1:00:55.A 150j treatment was delivered at 01:01:56.The rhythm at the time of treatment was vf.The post-shock rhythm was asystole.The pt remained in asystole.The electrode belt was disconnected at 01:13:19.The lifevest was shutdown at 01:43:45.The use of the response buttons prevented a treatment for approximately 5 minutes.It is unk who pressed the response buttons, as the patient was reportedly unconscious.Bystanders are alerted through alarms not to interfere with the lifevest.Post-shock asystole is a known possible outcome of defibrillation.
|